台股 » 個股 » 杏國 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

杏國

(4192)
  • 股價
    46.85
  • 漲跌
    ▲0.20
  • 漲幅
    +0.43%
  • 成交量
    5
  • 產業
    上櫃 生技醫療類股▼1.01%
  • 119人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
杏國 (4192)籌碼相關-元大-南海 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

元大-南海 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/04/2900.00648.5748.20-647-12.51%
2024/04/26652.5000.0052.5064413.37%
2022/04/2500.00134.8034.05-1339-0.29%
2022/04/11144.1500.0043.6012970.34%
2022/03/152.135.0600.0034.202.13160.66%
2022/03/14335.2500.0035.1033250.92%
2022/03/11235.2500.0035.3523340.60%
2022/03/080.535.8000.0035.200.53660.14%
2022/02/18131.8000.0031.9514490.22%
2022/02/091.232.3500.0033.101.26530.18%
2022/01/250.328.7000.0028.750.38650.04%
2022/01/24228.6000.0028.6028630.23%
2022/01/21129.3500.0029.0018610.12%
2021/12/02132.4000.0032.2511,4870.07%
2021/11/16442.9000.0045.0041,5030.27%
2021/11/1100.00441.6340.50-41,481-0.27%
2021/11/10445.8000.0043.9541,4890.27%
2021/11/0900.00142.5045.95-11,499-0.07%
2021/11/0500.00144.5043.05-11,501-0.07%
2021/11/04349.27147.9047.8021,4570.14%
2021/09/231108.0000.00108.0019770.10%
2021/08/3100.00189.2093.00-1641-0.16%
2021/08/30191.5000.0090.7016200.16%
2021/08/11178.3000.0078.3013650.27%
2021/08/1000.00196.0086.90-1340-0.29%
2021/08/05173.80173.7073.9003040.00%
2021/06/0200.00149.4549.40-1333-0.30%
2021/05/17156.5000.0057.6014010.25%
2021/03/29157.3000.0057.4012810.35%
2021/03/2400.00151.8052.90-1272-0.37%
2021/03/23152.2000.0051.7012680.37%
2021/02/2500.00157.4053.00-1270-0.37%
2021/02/24151.5000.0055.0012640.38%
2021/02/2300.00152.5051.60-1266-0.37%
2021/02/19148.8000.0049.4012530.39%
2021/01/0400.00245.8045.65-2273-0.73%
2020/12/22249.4000.0049.5022660.75%
2020/10/1400.00155.9055.90-1642-0.16%
2020/09/2500.00160.1060.30-1746-0.13%
2020/09/2100.00165.0065.00-1783-0.13%
2020/09/16164.0000.0061.8018230.12%
2020/09/1100.00163.5063.00-1840-0.12%
2020/08/3100.005277.7577.20-52946-5.50%
2020/08/18178.2000.0078.3019010.11%
2020/08/14181.1000.0079.0018900.11%
2020/07/29159.0000.0059.8017200.14%
2020/07/28558.4000.0058.4057110.70%
2020/07/22571.0000.0073.1056710.74%
2020/07/21566.8000.0066.5056670.75%
2020/07/2000.00273.9073.80-2647-0.31%
2020/07/153110.5000.00100.5035970.50%
2020/07/142111.5000.00111.5025620.36%
2020/07/131123.5000.00123.5015580.18%
2020/07/1025149.4000.00137.00255524.53%
2020/07/085128.5000.00128.5055140.97%
2020/07/0100.00180.3080.30-1468-0.21%
2020/06/24169.0000.0068.5014250.24%
2020/06/23273.8000.0072.1024070.49%
2020/06/1900.00165.6067.90-1357-0.28%
2020/06/1800.00169.1072.30-1334-0.30%
2020/06/1500.00161.6061.60-1270-0.37%
2020/06/12154.7000.0056.0012510.40%
2020/06/10154.1000.0054.4011820.55%
2020/06/0800.00143.7045.00-1143-0.70%
2020/06/01138.3000.0039.5011160.86%
2020/05/2800.00137.0036.25-1104-0.96%
2020/05/26136.00137.0036.000970.00%
2020/05/18132.1000.0032.101691.44%
2019/07/11128.9500.0029.001492.03%
2018/07/2600.00226.0025.85-242-4.71%
2018/06/1200.00227.2027.50-2105-1.89%
2018/03/20332.9000.0031.753813.66%
2018/02/09130.8000.0031.001541.85%
杏國將在歐洲腫瘤內科學會亞洲年會 發表胰臟癌臨床結果UDN聯合新聞網-2022/09/25
杏國胰臟癌新藥三期試驗喊卡 待美FDA通知補件Anue鉅亨-2022/05/18
杏國 相關文章